Enzymes in Addressing Hypoxia for Biomaterials Engineering

Pejman Ghaffari‐Bohlouli,Hafez Jafari,Lei Nie,Ashok Kakkar,Amin Shavandi

DOI: https://doi.org/10.1002/adhm.202401713

IF: 10

2024-08-27

Advanced Healthcare Materials

Abstract:Hypoxia affects cellular processes and plays a significant role in the progression of various human diseases. Stabilizing catalase to enzymatically decompose hydrogen peroxide and generate oxygen in situ presents a promising strategy to alleviate hypoxia. This approach could effectively address current challenges associated with oxygen carriers and generators. Oxygen is essential for normal cellular functions. Hypoxia impacts various cellular processes, such as metabolism, growth, proliferation, angiogenesis, metastasis, tumorigenesis, microbial infection, and immune response, mediated by hypoxia‐inducible factors (HIFs). Hypoxia contributes to the progression and development of cancer, cardiovascular diseases, metabolic disorders, kidney diseases, and infections. The potential alleviation of hypoxia has been explored through the enzymatic in situ decomposition of hydrogen peroxide, leading to the generation of oxygen. However, challenges such as limited stability restrict the effectiveness of enzymes such as catalase in biomedical and in vivo applications. To overcome these limitations, targeted delivery of the enzymes has been proposed. This review offers a critical comparison of i) current approaches to enhance the in vivo stability of catalase; and ii) the structure, mechanism of action, and kinetics of catalase and catalase‐like nanozymes.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials